Archive | May, 2013

Summary of the PPMI 2013 Annual Meeting in New York, NY

The 2013 PPMI Annual Meeting took place on May 7th & 8th in New York, NY. Site investigators, study staff, industry partner representatives, patient advisory committee members, Study Core members, and members of the Steering Committee gathered for a holistic overview of what has already been accomplished and what the future holds for PPMI.

Continue reading...

PPMI Cognitive Behavioral Working Group to Present at MDS Congress 2013 in Sydney, Australia

Daniel Weintraub of the PPMI Cognitive Behavioral Working Group will present on cognitive performance and psychiatric symptoms in early, untreated Parkinson disease at the MDS Congress 2013 in Sydney, Australia.

Continue reading...

PPMI Scientific Leadership to Present Poster on PPMI at MDS Congress 2013 in Sydney, Australia

The MDS Congress 2013 will take place in Sydney, Australia from June 16 to June 20. John Seibyl will present on SPECT Measures of PD progression during the Movement Disorders Session.

Continue reading...

Dr. John Q. Trojanowski to Present on PPMI at American Academy of Neuropathologists

Dr. Trojanowski, PI of the PPMI Bioanalytics Core will present an overview of PPMI at the American Academy of Neuropathologists to be held June 20-23, 2013 in Charleston, SC.

Continue reading...

PPMI Diffusion Tensor Imaging data presented at AD/PD 2013 in Florence, Italy

Yu Zhang from the University of California at San Francisco presented data on the visualization and quantification of the striato-pallidonigral fibers in PD using DTI at the 11th International Conference on Alzheimer's and Parkinson's Diseases in Florence, Italy.

Continue reading...

PPMI Scientific Leadership to Present on PPMI at 2013 SNMMI Annual Meeting

John Seibyl, member of the PPMI Steering Committee, will present on the initial quantitative 123-I Ioflupane SPECT one year disease progression data in the PPMI PD cohort.at The Society of Nuclear Medicine and Molecular Imaging?s 2013 Annual Meeting

Continue reading...

MDS 2013 Poster: ?Relationship between Serum Urate and Clinical Features in Early Parkinson?s Disease: PPMI Baseline Data?

A poster submitted by Radu Constantinescu, MD of the Center for Human Experimental Therapeutics (CHET) at the University of Rochester Medical Center has been accepted for the poster session at the Movement Disorder Society?s International Congress this June in Sydney, Australia.

Continue reading...

Feasibility and Safety of Lumbar Punctures in PPMI presented at AAN

Boston University PPMI Site Principal Investigator, Samuel Frank, presented data on the feasibility and safety of lumbar punctures in PPMI at the American Academy of Neurology?s 75th annual meeting on March 19th, 2013 in San Diego, CA.

Continue reading...